Press Releases
Please view the latest press from Enzo Biochem, Inc.
Date | Details |
Wednesday, December 19, 2007 | ENZO Biochem Unit Signs Letter Of Intent to Acquire Belgian Life Sciences Distributor Acquisition To Broaden Company’s Direct Sales Presence in Benelux Countries |
Monday, December 10, 2007 | ENZO Biochem Reports 2008 Fiscal First Quarter Results Revenue Increases 86%; Gross Profit Rises 56% |
Wednesday, December 05, 2007 | ENZO Biochem Schedules Teleconference to Discuss First Quarter 2008 Results for Tuesday December 11, 2007, At 8:30 AM E.T. |
Wednesday, November 21, 2007 | ENZO Biochem to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference |
Tuesday, October 30, 2007 | ENZO Biochem Reports On Potential Biomarker for Diagnosis of Non-Alcoholic Steatohepatitis (Nash) |
Thursday, October 25, 2007 | ENZO Biochem to Present at the Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference |
Monday, October 15, 2007 | ENZO Reports Improved Fourth Quarter and Fiscal 2007 Results Quarterly Revenue Increases 81%; Quarterly Operating Results Improve By $1.2 Million |
Wednesday, October 10, 2007 | Teleconference |
Tuesday, September 18, 2007 | ENZO Biochem to Present at UBS 2007 Global Life Sciences Conference |
Tuesday, September 18, 2007 | ENZO Biochem Reports Animal Study Supports Finding Of New Therapeutics for Treating Periodontal Bone Loss |
Friday, September 07, 2007 | ENZO Biochem, Inc. Files Appeal to Federal Court Decision |
Monday, June 11, 2007 | Enzo Biochem Reports Third Quarter Results |
Thursday, June 07, 2007 | Enzo Biochem Schedules Teleconference To Discuss Third Quarter Results For Tuesday June 12, 2007, At 8:30 Am E.T. |
Tuesday, June 05, 2007 | Enzo Life Sciences, Inc., Completes Acquisition Of Axxora Life Sciences, Inc. |
Wednesday, May 30, 2007 | ENZO Biochem Unit to Acquire Axxora Life Sciences, Inc. Global Reagent Manufacturer and Marketing Company |
Tuesday, May 22, 2007 | ENZO Biochem Individualized Oral Immune Regulation Therapy May Be Effective Approach to Treating Crohn’s Disease |
Thursday, May 03, 2007 | ENZO Biochem Announces Supply and Royalty Bearing Cross-Licensing Agreements with Abbott |
Tuesday, March 13, 2007 | Enzo Therapeutics Treats First Patient in Phase I/II Study of Antisense Gene Therapy for HIV-1 Infections |
Monday, March 12, 2007 | Enzo Biochem Reports Results For Fiscal 2007 Second Quarter And Six Month Periods |
Thursday, March 08, 2007 | Enzo Biochem Schedules Teleconference To Discuss Second Quarter Results |
Wednesday, March 07, 2007 | U.S. Patent Board Awards ENZO Biochem Judgment In Patent Interference After Princeton University Concedes Priority |
Wednesday, February 07, 2007 | Enzo Biochem Life Sciences Unit Awarded Two Patents That Enhance Competitive Position of Existing Products for Fast-Growing DNA Labeling and Arrays Fields |
Monday, February 05, 2007 | ENZO Biochem Raises $15 Million in Registered Direct Offering to A Leading Life Sciences Institutional Investor |
Thursday, January 25, 2007 | ENZO Biochem Strongly Positioned For Growth Opportunities, Annual Meeting Told |
Thursday, January 18, 2007 | Clinical Lab Subsidiary Announces New Senior Staff Additions |